# ACS Global, Inc.: Form D filings

ACS Global, Inc., a biotechnology company in Red Bank, NJ, filed 2 Form D notices with the SEC between 2009 and 2011. The latest, on July 1, 2011, reports $2.2 million sold of a $3 million offering to 62 investors.

Find out what ACS Global, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20ACS%20Global%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=ACS%20Global%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Facs-global-inc-1423912)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20ACS%20Global%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=ACS%20Global%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Facs-global-inc-1423912)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey): 714 rows, by operating companies, filed since November 1, 2024, $35.70, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-jersey
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 188 EAST BERGEN PLACE, SUITE 204, Red Bank, NJ, 07701
- Phone: (732) 747-1007
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Nevada
- Revenue range: $1 - $1,000,000
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1423912

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jul 1, 2011 | Amendment | $3,000,000 | $2,232,000 | $768,000 | 62 | Mar 11, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1423912/000093041311004619/0000930413-11-004619-index.htm) |
| Dec 2, 2009 | New notice | $1,000,000 | $225,000 | $775,000 | 30 | Mar 11, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1423912/000142391209000005/0001423912-09-000005-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| John Arnone | Executive Officer, Director |  |

## Other biotechnology companies in New Jersey that filed recently

- [Ensho Therapeutics, Inc.](https://specstream.ai/data/form-d/company/ensho-therapeutics-inc-2032849) $7.3 million · Oct 15, 2026
- [Xenon Ophthalmics Inc](https://specstream.ai/data/form-d/company/xenon-ophthalmics-inc-1988832) $3.3 million · Oct 6, 2026
- [LISATA THERAPEUTICS, INC.](https://specstream.ai/data/form-d/company/lisata-therapeutics-inc-320017) $351.9 million · Oct 2, 2026

[Every Form D from the week of Jun 27, 2011](https://specstream.ai/data/form-d/week/2011-06-27) · [All recent filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what ACS Global, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).